Columbia Laboratories, Inc.: A Specialty Pharmaceutical Company

Founded in 1986, Columbia Laboratories, Inc. and its subsidiaries continue to operate as a specialty pharmaceutical company. The business is headquartered in Boston, Massachusetts and continues to trade its common stocks publicly. It is on the NASDAQ that the company trades its common shares using the symbol CBRX.

As a pharmaceutical company, the business is engaged in the development, manufacturing, licensing and marketing of medications like CRINONE, which is progesterone gel for pregnant women. This product alone is marketed in 60 countries around the world through its partnership with Actavis, Inc. and Merck Serono S. A. They have several products in the pipeline and continues to leverage its product development on its clinical trial manufacturing, in-house pharmaceutical development and analytical capabilities. These capabilities are also offered to some pharmaceutical customers worldwide.

Listed as a component of the Wilshire 5000 Index, the business is soon to make a name change to reflect its new corporate name: Juniper Pharmaceuticals, Inc.